Oral gum composition

US2023098503A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023098503-A1
Application numberUS-202217955891-A
CountryUS
Kind codeA1
Filing dateSep 29, 2022
Priority dateSep 30, 2021
Publication dateMar 30, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure provides a composition configured for oral use. The composition includes a gum base, one or more bulking agents; an active ingredient having a basic amine functionality; and an organic acid, an alkali metal salt of an organic acid, or a combination thereof, wherein at least a portion the active ingredient having the basic amine functionality is associated with at least a portion of the organic acid or the alkali metal salt thereof, the association in the form of a basic amine-organic acid salt, an ion pair between the basic amine and a conjugate base of the organic acid, or both.

First claim

Opening claim text (preview).

1 . An oral composition comprising: a gum base; one or more bulking agents; an active ingredient having a basic amine functionality; and an organic acid, an alkali metal salt of an organic acid, or a combination thereof, wherein at least a portion the active ingredient having the basic amine functionality is associated with at least a portion of the organic acid or the alkali metal salt thereof, the association in the form of a basic amine-organic acid salt, an ion pair between the basic amine and a conjugate base of the organic acid, or both. 2 . The oral composition of claim 1 , in the form of a chewing gum. 3 . The oral composition of claim 1 , wherein at least a portion the active ingredient having the basic amine functionality is in the form of an ion pair between the basic amine and a conjugate base of the organic acid. 4 . The oral composition of claim 1 , wherein the organic acid has a log P value of from about 1 to about 12. 5 . The oral composition of claim 1 , wherein the organic acid has a log P value of from about 1.4 to about 4.5. 6 . The oral composition of claim 1 , wherein the organic acid has a log P value of from about 2.5 to about 3.5. 7 . The oral composition of claim 1 , wherein the organic acid has a log P value of from about 4.5 to about 12, and wherein the composition further comprises a solubility enhancer. 8 . The oral composition of claim 7 , wherein the solubility enhancer is glycerol or propylene glycol. 9 . The oral composition of claim 1 , comprising from about 0.05, about 0.1, about 1, about 1.5, about 2, or about 5, to about 10, about 15, or about 20 molar equivalents of the organic acid, the alkali metal salt thereof, or the combination thereof, relative to the active ingredient having a basic amine functionality, calculated as the amine free base. 10 . The oral composition of claim 1 , comprising from about 2 to about 10 molar equivalents of the organic acid, the alkali metal salt thereof, or the combination thereof, relative to the active ingredient having a basic amine functionality, calculated as the amine free base. 11 . The oral composition of claim 1 , wherein the organic acid comprises benzoic acid, a menthyl or tocopherol monoester of a dicarboxylic acid, or a combination thereof. 12 . The oral composition of claim 11 , wherein the dicarboxylic acid is malonic acid, succinic acid, glutaric acid, adipic acid, fumaric acid, maleic acid, or a combination thereof. 13 . The oral composition of claim 1 , wherein the organic acid comprises tocopherol succinate, monomenthyl succinate, monomenthyl fumarate, monomenthyl glutarate, or a combination thereof. 14 . The oral composition of claim 13 , further comprising benzoic acid and sodium benzoate. 15 . The oral composition of claim 1 , comprising benzoic acid and sodium benzoate. 16 . The oral composition of claim 1 , comprising the organic acid and an alkali metal salt of the organic acid. 17 . The oral composition of claim 16 , wherein the alkali metal is sodium or potassium. 18 . The oral composition of claim 1 , wherein a ratio of the organic acid to the alkali metal salt of the organic acid is from about 0.1 to about 10. 19 . The oral composition of claim 1 , wherein the pH of the composition is from about 4.0 to about 9.0. 20 . The oral composition of claim 1 , wherein the pH of the composition is from about 4.5 to about 7. 21 . The oral composition of claim 1 , wherein the pH of the composition is from about 5.5 to about 7. 22 . The oral composition of claim 1 , wherein the pH of the composition is from about 4.0 to about 5.5. 23 . The oral composition of claim 1 , wherein the pH of the composition is from about 7.0 to about 9.0. 24 . The oral composition of claim 1 , wherein the active ingredient having a basic amine functionality is nicotine. 25 . The oral composition of claim 24 , wherein the nicotine is present in an amount of from about 0.001 to about 10% by weight of the composition, calculated as the free base and based on the total weight of the composition. 26 . The oral composition of claim 24 , wherein the oral composition comprises a nicotine salt such as nicotine benzoate, nicotine polacrilex, or a combination thereof. 27 . The oral composition of claim 1 , wherein the gum base comprises a synthetic elastomer. 28 . The oral composition of claim 27 , wherein the gum base further comprises a plasticizer, a filler, a softener, an emulsifier, a wax, an anti-tacking agent, an antioxidant, or a combination thereof. 29 . The oral composition of claim 1 , wherein the bulking agent comprises one or more sugar alcohols. 30 . The oral composition of claim 1 , wherein the oral composition comprises, as the bulking agent, a combination of: sorbitol in an amount from about 25 to about 50% by weight; maltitol in an amount from about 10 to about 20% by weight; and isomalt in an amount from about 10 to about 20% by weight, each based on the total weight of the oral composition. 31 . The oral composition of claim 1 , further comprising one or more additional active ingredients, one or more flavoring agents, one or more salts, one or more sweeteners, one or more humectants, a tobacco material, or combinations thereof. 32 . The oral composition of claim 1 , further comprising one or more additional active ingredients selected from the group consisting of nutraceuticals, botanicals, stimulants, amino acids, vitamins, cannabinoids, cannabimimetics, and terpenes. 33 . The oral composition of claim 1 , comprising: the gum base in an amount from about 20 to about 30% by weight, based on the total weight of the oral composition; the bulking agent in an amount from about 50 to about 80% by weight, based on the total weight of the oral composition, wherein the bulking agent comprises one or more sugar alcohols; a humectant in an amount from about 1 to about 2% by weight, based on the total weight of the oral composition; nicotine benzoate; and sodium benzoate. 34 . The oral composition of claim 33 , further comprising nicotine polacrilex. 35 . The oral composition of claim 1 , comprising: the gum base in an amount from about 20 to about 30% by weight, based on the total weight of the oral composition; the bulking agent in an amount from about 50 to about 80% by weight, based on the total weight of the oral composition, wherein the bulking agent comprises one or more sugar alcohols; a humectant in an amount from about 1 to about 2% by weight, based on the total weight of the oral composition; nicotine polacrilex; and sodium benzoate. 36 . The oral composition of claim 1 , further comprising flavor granules. 37 . The oral composition of claim 36 , wherein the flavor granules comprise: a sugar alcohol in an amount by weight from about 60 to about 90%; a humectant in an amount by weight from about 16 to about 22%; a sweetener in an amount by weight from about 0.1 to about 0.5%; a filler in an amount by weight from about 1 to about 3%; a colorant; and a flavorant, wherein each amount by weight is based on the total weight of the flavor granules. 38 . The oral composition of claim 36 , wherei

Assignees

Inventors

Classifications

  • Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff (reconstituted tobacco products A24B3/14) · CPC title

  • Carboxylic acids; Salts or anhydrides thereof · CPC title

  • by encapsulation of the chemical substances · CPC title

  • Chewing gum · CPC title

  • Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023098503A1 cover?
The disclosure provides a composition configured for oral use. The composition includes a gum base, one or more bulking agents; an active ingredient having a basic amine functionality; and an organic acid, an alkali metal salt of an organic acid, or a combination thereof, wherein at least a portion the active ingredient having the basic amine functionality is associated with at least a portion …
Who is the assignee on this patent?
Nicoventures Trading Ltd
What technology area does this patent fall under?
Primary CPC classification A61K9/0058. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Mar 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).